title: Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
authors.affiliation: Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
authors.forename: Grégoire
authors.initials: G
authors.lastname: Berthod
authors.forename: Romain
authors.initials: R
authors.lastname: Lazor
authors.forename: Igor
authors.initials: I
authors.lastname: Letovanec
authors.forename: Emanuela
authors.initials: E
authors.lastname: Romano
authors.forename: Leslie
authors.initials: L
authors.lastname: Noirez
authors.forename: Jessica
authors.initials: J
authors.lastname: Mazza Stalder
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Speiser
authors.forename: Solange
authors.initials: S
authors.lastname: Peters
authors.forename: Olivier
authors.initials: O
authors.lastname: Michielin
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D006099:Granuloma / Q000139:chemically induced* / Q000150:complications; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D000074324:Ipilimumab; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000150:complications; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal; D000074324:Ipilimumab